Hadasit Bio-Holdings Ltd (HSITF) Stock Analysis
DELISTED
What happened to Hadasit Bio-Holdings Ltd (HSITF) stock?
Hadasit Bio-Holdings Ltd (HSITF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $1.33M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Hadasit Bio-Holdings Ltd (HSITF). Hadasit Bio-Holdings Ltd is an Israeli biotechnology company focusing on developing therapeutics in oncology, regenerative medicine, and inflammatory diseases. Their lead product is ProtAb, an immunotherapeutic monoclonal antibody targeting autoimmune inflammatory conditions.
Last analyzed: Mar 18, 2026Hadasit Bio-Holdings Ltd (HSITF) Healthcare & Pipeline Overview
HSITF OTC Market Information
HSITF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy HSITF shares?
No. HSITF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for HSITF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before HSITF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Hadasit Bio-Holdings Ltd. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.